Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Apr 30, 2019 5:59pm

105 Views

Post# 29691362

RE:Insider

Ah ha.

This is a start.

Let’s see more of this.

bfw

thisisriskystuf wrote:

Filing

Date Transaction

Date Insider Name Ownership

Type Securities Nature of transaction Volume or Value Price

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 500 $6.66

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 500 $6.65

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 200 $6.64

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 900 $6.63

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 400 $6.62

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 500 $6.61

Apr 18/19 Apr 18/19 Lafond, Jocelyn Direct Ownership Common Shares 10 - Disposition in the public market -3,600 $7.01

Apr 18/19 Apr 18/19 Lafond, Jocelyn Direct Ownership Common Shares 10 - Disposition in the public market -4,400 $7.05

Apr 23/19 Apr 18/19 Talon, Jean-Denis Direct Ownership Options Amended Filing 51 - Exercise of options -10,000

Apr 18/19 Apr 18/19 Talon, Jean-Denis Direct Ownership Common Shares 51 - Exercise of options 10,000 $1.84

Filing
Date Transaction
Date Insider Name Ownership
Type Securities Nature of transaction Volume or Value Price

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 500 $6.66

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 500 $6.65

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 200 $6.64

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 900 $6.63

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 400 $6.62

Apr 30/19 Apr 30/19 Dubuc, Philippe Direct Ownership Common Shares 10 - Acquisition in the public market 500 $6.61

Apr 18/19 Apr 18/19 Lafond, Jocelyn Direct Ownership Common Shares 10 - Disposition in the public market -3,600 $7.01

Apr 18/19 Apr 18/19 Lafond, Jocelyn Direct Ownership Common Shares 10 - Disposition in the public market -4,400 $7.05

Apr 23/19 Apr 18/19 Talon, Jean-Denis Direct Ownership Options 51 - Exercise of options -10,000

Apr 18/19 Apr 18/19 Talon, Jean-Denis Direct Ownership Common Shares 51 - Exercise of options 10,000

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Apr 30/19	Apr 30/19	Dubuc, Philippe	Direct Ownership	Common Shares	10 - Acquisition in the public market	500	$6.66
Apr 30/19	Apr 30/19	Dubuc, Philippe	Direct Ownership	Common Shares	10 - Acquisition in the public market	500	$6.65
Apr 30/19	Apr 30/19	Dubuc, Philippe	Direct Ownership	Common Shares	10 - Acquisition in the public market	200	$6.64
Apr 30/19	Apr 30/19	Dubuc, Philippe	Direct Ownership	Common Shares	10 - Acquisition in the public market	900	$6.63
Apr 30/19	Apr 30/19	Dubuc, Philippe	Direct Ownership	Common Shares	10 - Acquisition in the public market	400	$6.62
Apr 30/19	Apr 30/19	Dubuc, Philippe	Direct Ownership	Common Shares	10 - Acquisition in the public market	500	$6.61
Apr 18/19	Apr 18/19	Lafond, Jocelyn	Direct Ownership	Common Shares	10 - Disposition in the public market	-3,600	$7.01
Apr 18/19	Apr 18/19	Lafond, Jocelyn	Direct Ownership	Common Shares	10 - Disposition in the public market	-4,400	$7.05
Apr 23/19	Apr 18/19	Talon, Jean-Denis	Direct Ownership	Options	51 - Exercise of options	-10,000
Apr 18/19	Apr 18/19	Talon, Jean-Denis	Direct Ownership	Common Shares	51 - Exercise of options	10,000